Tower Research Capital LLC (TRC) - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 38 filers reported holding LIANBIO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LIANBIO
ValueSharesWeighting
Q2 2023$2,002
+14200.0%
878
-89.7%
0.00%
-100.0%
Q4 2022$14
-100.0%
8,519
-59.0%
0.00%0.0%
Q3 2022$41,000
+1266.7%
20,773
+1695.4%
0.00%
Q2 2022$3,000
-86.4%
1,157
-80.4%
0.00%
Q1 2022$22,0005,9030.00%
Other shareholders
LIANBIO shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$8,467,0004.92%
Perceptive Advisors 56,319,960$208,947,0004.18%
VR Adviser, LLC 5,378,341$19,954,0003.23%
SCHF (GPE), LLC 937,500$3,478,0001.08%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$12,296,0000.73%
RA Capital Management 7,655,015$28,400,0000.62%
Logos Global Management LP 412,837$1,532,0000.20%
Affinity Asset Advisors, LLC 325,000$1,206,0000.19%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,020,0000.14%
MYDA Advisors LLC 86,000$319,0000.13%
View complete list of LIANBIO shareholders